References
- Heykants J., Van Peer A., Van de Velde V., Van Rooy P., Meuledermans W., Lavrijsen K., Woestenborghs R., Van Custem J., Cauwenbergh G. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 1989; 32: 67–87
- De Beule K. Itraconazole: pharmacology, clinical experience and future development. Int. J. Antimicrob. Agents 1996; 6: 175–181
- Kauffman C.A., Carver P.L. Antifungal agents in the 1990s. Current status and future developments. Drugs 1997; 53: 539–549
- Schott H., Kwan L.C., Feldman S. The role of surfactant in the release of very slightly soluble drugs from tablets. J. Pharm. Sci. 1982; 71: 1038–1045
- Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 1996; 85: 1017–1025
- Miyake K., Irie T., Arima H., Hirayama F., Uekama K., Hirano M., Okamoto Y. Characterization of itraconazole/2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int. J. Pharm. 1999; 179: 237–245
- Magenheim B., Benita S. Nanoparticle characterization: a comprehensive physicochemical approach. S.T.P. Pharma Sci. 1991; 1: 221–241
- Hancock B.C., Zografi G. Characteristics and significance of amorphous state in pharmaceutical systems. J. Pharm. Sci. 1997; 86: 1–11
- Gruenhagen H.H., Müller O. Melt extrusion technology. Pharm. Manuf. Int. 1995; 167–170
- Serajuddin A.T.M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999; 88: 1058–1066
- Jung J.-Y., Yoo S.D., Lee S.-H., Kim K.-H., Yoon D.-S., Lee K.-H. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int. J. Pharm. 1999; 187: 209–218
- Gruenhagen H.H. Polymer drug-melt-extrusion: therapeutic and technological appeal. Pharm. Tech. Europe 1996; 8: 22–28
- Cuff G., Raof F. A preliminary evaluation of injection molding as a technology to produce tablets. Pharm. Techn. 1998; 22: 96–106
- Henrist D., Remon J.P. Influence of the process parameters on the characteristics of starch based hot stage extrudates. Int. J. Pharm. 1999a; 189: 7–17
- Henrist D., Remon J.P. Influence of the formulation composition on the in vitro characteristics of hot stage extrudates. Int. J. Pharm. 1999b; 189: 7–17
- Baert L.E.C., Verreck G. Solid mixtures of cyclodextrins prepared via melt-extrusion. PCT Int. Appl. 1997a, WO 97/18839
- Loftsson T. Cyclodextrin complexation. U.S. Pat. No. 5,472,954, 1995
- Baert L.E.C., Verreck G. Antifungal compositions with improved bioavailability. PCT Int. Appl. 1997b, WO 97/44014
- Gilis P.M.V., De Conde V.F.V., Vandecruys R.P.G. Pharmaceutical beads having a core coated with an antifungal and a polymer. PCT Int. Appl. 1994, WO 94/05263
- Huisman R., Van Kamp H.V., Weyland J.W., Doornbos D.A., Bolhuis G.K., Lerk C.F. Development and optimization of pharmaceutical formulations using a simplex lattice design. Pharm. Weekblad Sci. 1984; 6: 185–194
- Lewis G.A., Chariot M. Non classical experimental designs in pharmaceutical formulation. Drug Dev. Ind. Pharm. 1991; 17: 1551–1570
- Bodea A., Leucata S.E. Optimization of hydrophilic matrix tablets using a D-optimal design. Int. J. Pharm. 1997; 153: 247–255
- Lu Q., Zografi G. Properties of citric acid at the glass transition. J. Pharm. Sci. 1997; 86: 1374–1378
- Ford J.L., Timmins P. Pharmaceutical Thermal Analysis. Techniques and Applications. Ellis Horwood limited, West SussexEngland 1989; 313 pp
- Cornell J.A. Experiments with Mixtures, 2nd Ed. Wiley, New York 1990
- Six K., Verreck G., Peeters J., Binnemans K., Bergmans K., Augustijns P., Kinget R., Van den Mooter G. Investigation of thermal properties of glassy itraconazole: identification of monotropic mesophase. Thermchim. Acta 2001; 376: 175–181
- Hancock B.C., Shamblin S.L., Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm. Res. 1995; 12: 799–806